Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience

Implementation of recombinant anti-herpes zoster vaccination in people living with HIV: a single-center experience

People living with HIV (PLWH) are at high risk of herpes zoster (HZ). The recombinant anti-HZ vaccine (RZV), approved by European Medicines Agency (EMA) in 2018, has been shown to be effective and safe in PLWH. This study aims to describe the implementation of RZV in our center. Prospective cohort s...

Full description

Saved in:
Bibliographic Details
Main Authors: Benedetta Trentacapilli, Angelo Roberto Raccagni, Sara Diotallevi, Silvia Nozza, Riccardo Lolatto, Anna Carole D’Amelio, Gaia Catalano, Giacomo Ponta, Vincenzo Spagnuolo, Massimo Cernuschi, Nicola Gianotti, Antonella Castagna, Diana Canetti
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Virology
Subjects:
herpes zoster
proactive vaccination
HIV
implementation
prioritization
Online Access:https://www.frontiersin.org/articles/10.3389/fviro.2025.1537821/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fviro.2025.1537821/full

Similar Items